Synonyms: CK-4021586 | CK586 | compound 4 [WO2022187501A1]
Compound class:
Synthetic organic
Comment: CK-586 is an oral cardiac myosin inhibitor [2]. It is one of the compounds claimed in Cytokinetics' patent WO2022187501A1
|
|
No information available. |
Summary of Clinical Use ![]() |
CK-586 is a clinical lead for the treatment of hypertrophic cardiomyopathy. |
Clinical Trials | |||||
Clinical Trial ID | Title | Type | Source | Comment | References |
NCT05877053 | A Single and Multiple Ascending Dose Study of CK-4021586 in Healthy Adult Participants | Phase 1 Interventional | Cytokinetics |